Biological markers of activity in chronic inflammatory bowel disease
Sánchez Lombraña, J.; Palacio, M.A.; Carbajal, C.; Vivas, S.; Pérez, R.; Rodrigo, L.
Revista Espanola de Enfermedades Digestivas Organo Oficial de la Sociedad Espanola de Patologia Digestiva 89(11): 855-858
1997
ISSN/ISBN: 1130-0108 PMID: 9580203 Document Number: 475772
Document emailed within 1 workday
Related Documents
Geboes, K.; Desreumaux, P.; Jouret, A.; Ectors, N.; Rutgeerts, P.; Colombel, J.F. 1999: Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. use of histological scores Gastroenterologie Clinique et Biologique 23(10): 1062-1073Mokrowiecka, A.; Daniel, P.; Słomka, M.; Majak, P.ł; Malecka-Panas, E. 2009: Clinical utility of serological markers in inflammatory bowel disease Hepato-Gastroenterology 56(89): 162-166
Van Deventer, S.J. 2001: Biological therapies of inflammatory bowel disease Acta Gastro-Enterologica Belgica 64(2): 177-181
Su, C.G..; Judge, T.A..; Lichtenstein, G.R.. 2001: The role of biological therapy in inflammatory bowel disease Drugs of Today 37(2): 121-133
Qian, J.-m.; Tang, H. 2013: Status of biological agent therapy in inflammatory bowel disease Zhonghua Wei Chang Wai Ke Za Zhi 16(4): 311-314
Guerra, I.án.; Bermejo, F. 2015: Biological drugs in inflammatory bowel disease: Management and care Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 107(7): 454
Desreumaux, P.; Bourreille, A.; Colombel, J.-F.éd.ér. 2003: Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring? Gastroenterologie Clinique et Biologique 27(3 Suppl): S81-S86
Gould, M. 2013: Biological therapies improve inflammatory bowel disease symptoms, national audit finds Bmj 347: F5340
Becker, K.; Niederau, C.; Frieling, T. 1999: Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease Zeitschrift für Gastroenterologie 37(7): 597-605
Das, S.K.; Montgomery, R.D. 1978: Chronic inflammatory bowel disease in Asian immigrants Practitioner 221(1325): 747-749
Hylander, E.; Jarnum, S.; Frandsen, I. 1979: Urolithiasis and hyperoxaluria in chronic inflammatory bowel disease Scandinavian Journal of Gastroenterology 14(4): 475-479
Bøggild, H.; Tüchsen, F.; Orhede, E. 1998: Occupational and chronic inflammatory bowel disease in Denmark Ugeskrift for Laeger 160(10): 1470-1475
Faurschou, P.; Maltbaek, N.; Skov, B.G. 2005: Pulmonary diseases and chronic inflammatory bowel disease Ugeskrift for Laeger 167(1): 38-40
Limberg, B. 1999: Diagnosis of chronic inflammatory bowel disease by ultrasonography Zeitschrift für Gastroenterologie 37(6): 495-508
Teisberg, P.; Gjone, E. 1975: Humoral immune system activity in inflammatory bowel disease Scandinavian Journal of Gastroenterology 10(5): 545-549
Packer, N.; Hoffman-Goetz, L.; Ward, G. 2010: Does physical activity affect quality of life, disease symptoms and immune measures in patients with inflammatory bowel disease? a systematic review Journal of Sports Medicine and Physical Fitness 50(1): 1-18
Jacobsen, C.D.; Skjøtø, J.; Pytte, R.; Lygren, I. 1994: Follow-up of chronic inflammatory bowel disease. a 10-year material Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(6): 674-677
Saro Gismera, C.; Lacort Fernández, M.; Argüelles Fernández, G.; Antón Magarzo, J.; Navascues, C.A.; Garcia López, R.; Suárez González, A.; Diaz Alvarez, G.; Palacios Galán, A.; Altadill arregui, A.; Vizoso, F.; González Bernal, A.; Martínez, A. 2001: Epidemiology of chronic inflammatory bowel disease in Gijón, Asturias Gastroenterologia y Hepatologia 24(5): 228-235
Reimund, J.-M. 2003: Leptin and chronic inflammatory bowel disease: the human labyrinth Gastroenterologie Clinique et Biologique 27(11): 983-985
Kolacek, S. 2002: Role of enteral nutrition in the treatment of chronic inflammatory bowel disease Medicinski Arhiv 56(1 Suppl 1: 21-22